Clinical trial
A Randomized Evaluation of Clinical Outcomes Following Bilateral Implantation of EVO+ ICL Lenses or Bilateral Wavefront-Optimized LASIK (EVOlve)
NCT06700460 is registered in ClinicalTrials.gov with Vance Thompson Vision as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Evaluation of Clinical Outcomes Following Bilateral Implantation of EVO+ ICL Lenses or Bilateral Wavefront-Optimized LASIK (EVOlve)
- Lead sponsor
- Vance Thompson Vision
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 27, 2024
- Completion date
- November 13, 2025
- Enrollment
- 54 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.